Next Article in Journal
Effectiveness of Nivolumab in Second-Line and Later in Patients with Advanced Non-Small Cell Lung Cancer in Real-Life Practice in France and Germany: Analysis of the ESME-AMLC and CRISP Cohorts
Next Article in Special Issue
Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status
Previous Article in Journal
Lung Cancer Immunotherapy: Beyond Common Immune Checkpoints Inhibitors
Previous Article in Special Issue
Calorimetric Markers for Detection and Monitoring of Multiple Myeloma
 
 
Review

Article Versions Notes

Cancers 2022, 14(24), 6147; https://doi.org/10.3390/cancers14246147
Action Date Notes Link
article xml file uploaded 13 December 2022 11:08 CET Original file -
article xml uploaded. 13 December 2022 11:08 CET Update https://www.mdpi.com/2072-6694/14/24/6147/xml
article pdf uploaded. 13 December 2022 11:08 CET Version of Record https://www.mdpi.com/2072-6694/14/24/6147/pdf
article html file updated 13 December 2022 11:10 CET Original file -
article html file updated 1 March 2023 03:58 CET Update -
article html file updated 4 March 2023 21:18 CET Update https://www.mdpi.com/2072-6694/14/24/6147/html
Back to TopTop